Abstract:Multimodal nanoparticles have been extensively studied for target-specific imaging and therapy of various diseases, including cancer. In this study, radiolabeled arginine-glycine-aspartic acid (RGD)-functionalized Er(3+)/Yb(3+) co-doped NaGdF(4) upconversion nanophosphors (UCNPs) were synthesized and evaluated as a multimodal PET/MR/optical probe with tumor angiogenesis-specific targeting properties. Methods: A dimeric cyclic RGDyk ((cRGDyk)(2)) peptide was conjugated to polyacrylic acid-coated NaGdF(4):Yb(3+)/Er(3+) UCNPs along with polyethylene glycol molecules and was consecutively radiolabeled with (124)I. In vitro cytotoxicity testing was performed for 3 d. Upconversion luminescence imaging of (cRGDyk)(2)-UCNP was performed on U87MG cells with a laboratory-made confocal microscope. In vivo small-animal PET and clinical 3-T T1-weighted MR imaging of (124)I-labeled RGD-functionalized UCNPs was acquired with or without blocking of cyclic RGD peptide in a U87MG tumor model. Inductively coupled plasma mass spectrometry and biologic transmission electron microscopy were done to evaluate gadolinium concentration and UCNP localization, respectively. Results: Polymer-coated UCNPs and dimeric RGD-conjugated UCNPs were monodispersely synthesized, and those of hydrodynamic size were 30 ± 8 nm and 32 ± 9 nm, respectively. (cRGDyk)(2)-UCNPs have a low cytotoxic effect on cells. Upconversion luminescence signals of (cRGDyk)(2)-UCNP were specifically localized on the surface of U87MG cells. (124)I-c(RGDyk)(2)-UCNPs specifically accumulated in U87MG tumors (2.8 ± 0.8 vs. 1.3 ± 0.4 percentage injected dose per gram in the blocking experiment), and T1-weighted MR images showed significant positive contrast enhancement in U87MG tumors. Tumor localization of (124)I-c(RGDyk)(2)-UCNPs was confirmed by inductively coupled plasma mass spectrometry and biologic transmission electron microscopy analysis. Conclusion: These results suggest that (124)I-labeled RGD-functionalized UCNPs have high specificity for α(v)β(3) integrin-expressing U87MG tumor cells and xenografted tumor models. Multimodal UCNPs can be used as a platform nanoparticle with multimodal imaging for cancer-specific diagnoses.

Fabrication of RGD-conjugated Gd(OH) 3 :Eu nanorods with enhancement of magnetic resonance, luminescence imaging and in vivo tumor targeting.

Fabrication of Eu-Doped Gd(Oh)(3) Nanorods with Enhanced Magnetic- Resonance and Luminescence Imaging

Rgd/Ctx-Conjugated Multifunctional Eu-Gd2o3 Nrs for Targeting Detection and Inhibition of Early Tumor

Facile Preparation and Bifunctional Imaging of Eu-doped GdPO4 Nanorods with MRI and Cellular Luminescence

Construction of cRGD-iron oxide nanoparticles and its application in the tumor diagnosis by magnetic resonance imaging

Novel lanthanide–polymer complexes for dye-free dual modal probes for MRI and fluorescence imaging

RGD peptide-conjugated multimodal NaGdF4:Yb3+/Er3+ nanophosphors for upconversion luminescence, MR, and PET imaging of tumor angiogenesis

Fabrication of Gd/Eu-codoped SmPO4 Nanorods for Dual-Modal Magnetic Resonance and Bio-Optical Imaging.

Sub-10 Nm Monoclinic Gd2O3:Eu3+ Nanoparticles As Dual-Modal Nanoprobes for Magnetic Resonance and Fluorescence Imaging.

Magnetic Resonance Imaging Contrast Agent: Crgd-Ferric Oxide Nanometer Particle and Its Role in the Diagnosis of Tumor

Long-circulating Gd2O3:Yb3+, Er3+ Up-Conversion Nanoprobes As High-Performance Contrast Agents for Multi-Modality Imaging

Hybrid Mesoporous Gadolinium Oxide Nanorods: a Platform for Multimodal Imaging and Enhanced Insoluble Anticancer Drug Delivery with Low Systemic Toxicity

Gd(III) Functionalized Gold Nanorods for Multimodal Imaging Applications.

RGD-conjugated dendrimer-modified gold nanorods for in vivo tumor targeting and photothermal therapy.

Fabrication of Doxorubicin and Chlorotoxin-Linked Eu-Gd2O3 Nanorods with Dual-Model Imaging and Targeted Therapy of Brain Tumor

Gadolinium Oxysulfide-Coated Gold Nanorods with Improved Stability and Dual-Modal Magnetic Resonance/photoacoustic Imaging Contrast Enhancement for Cancer Theranostics.

A Synergistically Enhanced T-1 And T-2-Weighted Magnetic Resonance/Near-Infrared Contrast Agent Of Gd-Doping Fe3o4@Fluorescence Pegylated Nanoparticles For Multimodality Imaging Of Hepatocarcinoma

Europium doped gadolinium oxide nanoparticles for magnetic resonance and fluorescence imaging application

Facile Fabrication of Hollow Mesoporous Eu 3+ -Doped Gd 2 O 3 Nanoparticles for Dual-Modal Imaging and Drug Delivery

Triple-functional core-shell structured upconversion luminescent nanoparticles covalently grafted with photosensitizer for luminescent, magnetic resonance imaging and photodynamic therapy in vitro.

Facile Synthesis of Single‐Phase Mesoporous Gd2O3:Eu Nanorods and Their Application for Drug Delivery and Multimodal Imaging